Quince Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-02-14. The offering totals $8.0M, of which $7.6M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Stephen A Dominy | Director | South San Francisco, CA |
| David A Lamond | Director | San Francisco, CA |
| Margi A McLoughlin | Director | South San Francisco, CA |
| Roger A Quy | Director | Mill Valley, CA |
| Ilan A Zipkin | Director | Belmont, CA |
| CASEY LYNCH | Director | BOISE, ID |
| CASEY LYNCH | Executive Officer | BOISE, ID |
| Una Ryan | Director | South San Francisco, CA |
| David Lamond | Director | South San Francisco, CA |
| David Lamond | Related Person | South San Francisco, CA |
| Christopher Senner | Director | South San Francisco, CA |
| Christopher Senner | Related Person | South San Francisco, CA |
| Charles Ryan | Executive Officer | South San Francisco, CA |
| Charles Ryan | Related Person | South San Francisco, CA |
| Margi McLoughlin | Director | South San Francisco, CA |
| June Bray | Director | South San Francisco, CA |
| June Bray | Related Person | South San Francisco, CA |
| Luca Benatti | Director | South San Francisco, CA |
| Brendan Hannah | Executive Officer | South San Francisco, CA |
| Brendan Hannah | Related Person | South San Francisco, CA |
| Dirk Thye | Director | South San Francisco, CA |
| Dirk Thye | Executive Officer | South San Francisco, CA |
| Dirk Thye | Related Person | South San Francisco, CA |
| Rajiv Patni | Director | South San Francisco, CA |
| Ilan Zipkin | Director | OAKLAND, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-06-11 | D | $186.4M | $114.7M |
| 2026-06-11 | D | $7.4M | — |
| 2025-07-01 | D | $21.9M | $11.5M |
| 2018-05-31 | D | $85.6M | $84.5M |
| 2016-01-05 | D | $15.9M | $7.9M |